| Carter Lisette Starr, MD | |
|
6670 Green Dr, Trussville, AL 35173-2610 | |
| (205) 537-3337 | |
| Not Available |
| Full Name | Carter Lisette Starr |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 6670 Green Dr, Trussville, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720046972 | NPI | - | NPPES |
| 272760 | Medicaid | SC |
| Entity Name | Mcleod Regional Medical Center Of The Pee Dee, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154371433 PECOS PAC ID: 7416851852 Enrollment ID: O20031126000251 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
| Entity Name | Greenville Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568532513 PECOS PAC ID: 8123938131 Enrollment ID: O20031212000723 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
| Entity Name | Acs Primary Care Physicians - Southeast Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861430555 PECOS PAC ID: 5193620714 Enrollment ID: O20090401000270 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
| Entity Name | Baptist Easley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144452889 PECOS PAC ID: 0840337606 Enrollment ID: O20091027000684 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
| Entity Name | Acs Emergency Physicians Of Sc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124355375 PECOS PAC ID: 0648311506 Enrollment ID: O20100114000254 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
| Entity Name | Sound Physicians Emergency Medicine Of South Carolina Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730636168 PECOS PAC ID: 2163702739 Enrollment ID: O20161219000460 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carter Lisette Starr, MD 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (803) 933-6009 | Carter Lisette Starr, MD 6670 Green Dr, Trussville, AL 35173-2610 Ph: (205) 537-3337 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.
A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day- and for good reason.
Experts from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research findings at the American Heart Association Scientific Sessions 2011 held November 12-16, 2011 in Orlando, Florida.
The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.
› Verified 4 days ago
Dr. Brandon Buchel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6670 Green Dr, Trussville, AL 35173 Phone: 205-537-3337 | |
Dr. Nathaniel Lisenbee, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6670 Green Dr, Trussville, AL 35173 Phone: 205-537-3337 | |
Susana Ho, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6670 Green Dr, Trussville, AL 35173 Phone: 205-537-3337 | |
Nathaniel B. Jones, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6670 Green Dr, Trussville, AL 35173 Phone: 205-537-3337 |